Advertisement

Molecular and Cellular Biochemistry

, Volume 455, Issue 1–2, pp 61–71 | Cite as

Hypertension and longevity: role of genetic polymorphisms in renin-angiotensin-aldosterone system and endothelial nitric oxide synthase

  • Alda Pereira da SilvaEmail author
  • Andreia Matos
  • Laura Aguiar
  • Nuno Ramos-Marques
  • Ricardo Ribeiro
  • Ângela Gil
  • João Gorjão-Clara
  • Manuel Bicho
Article
  • 136 Downloads

Abstract

Hypertension (HT), a common age-related disorder, is an important risk factor for cardiovascular disease. This study aims to identify the prevalence of HT in Portuguese centenarians and evaluate whether gene polymorphisms encoding key molecules in blood pressure (BP) regulation are associated with longevity. There were recruited 253 centenarians (100.26 ± 1.98 years) and 268 control subjects (67.51 ± 3.25 years). Hypertension (ESH/ESC2013 and JNC8) and diabetes (WHO) were evaluate. Genetic polymorphisms of renin-angiotensin-aldosterone system (RAAS) and NOS3 were determined. The prevalence of HT among centenarians was 64.4% and the majority (58.9%) were controlled, differing from control group both on frequency (P < 0.001) and on their control (P < 0.001). We found that HT is a risk factor for not achieving longevity (OR 2.531, 95% CI 1.688–3.793, P < 0.001), the same for diabetes (OR 5.669 95% CI 2.966–10.835, P < 0.001), and male gender (OR 2.196, 95% CI 1.493–3.29, P < 0.001). Hypertension, adjusted for gender and diabetes, was independent risk factor anti-longevity (OR 2.007, 95% CI 1320–3.052, P = 0.001). The ACE_D and NOS3_G alleles were more frequent in centenarians compared to controls (P < 0.001, both cases). ACE_II and NOS3_TT genotypes, adjusted for BP, gender and diabetes, increased risk in 3.748 (95% CI 1.887–7.444) and 2.533 (95% CI 1.483–4.327), respectively, in relation to ACE_DD (P < 0.001) and NOS3_GG (P = 0.001), against longevity. Our findings suggest that the prevalence of hypertension was lower in Portuguese centenarians than in the elderly, reinforcing the importance of better cardiovascular risk profiles to achieve longevity even in the presence of genetic condition.

Keywords

Hypertension Centenarians ACE NOS3 Genetic polymorphism Longevity 

Notes

Acknowledgements

The authors would like to thank for the support given: Fausto Pinto (MD, PhD) Dean of Faculdade de Medicina da Universidade de Lisboa and Director of Department of Heart and Vessels of Hospital de Santa Maria; Dulce Brito (MD, PhD), Department of Cardiology, Hospital Santa Maria; António Nunes Diogo (MD) and Armando Bordalo (MD), UTIC/Arsénio Cordeiro Department, Hospital Santa Maria; Brás Nogueira (MD, PhD), Hypertension Department, Hospital Santa Maria; Lúcio Botas (MD, PhD), Department of Cardiology outpatients, Hospital Santa Maria; Susana Rodrigues Santos (PhD), HeartGenetics, Genetics and Biotechnology. Finally, thanks to Sara Cardoso (Social Researcher and Writer, Lisboa) for the precious help in establishing contacts and to César Oliveira for operational collaboration in the fieldwork.

Compliance with ethical standards

Conflict of interest

The author declares that they have no competing interests.

Ethical approval

The experiments comply with the current laws of Portugal in which the work was performed.

References

  1. 1.
    World Health Organization (2002) The World health report 2002—reducing risks, promoting healthy life. Geneva, SwitzerlandGoogle Scholar
  2. 2.
    Polonia J, Martins L, Pinto F, Nazare J (2014) Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal. J Hypertens 32:1211–1221.  https://doi.org/10.1097/HJH.0000000000000162 CrossRefGoogle Scholar
  3. 3.
    Macedo ME, Lima MJ, Silva AO et al (2005) Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study. J Hypertens 23:1661–1666CrossRefGoogle Scholar
  4. 4.
    Zyczkowska J, Klich-Raczka A, Mossakowska M et al (2004) Blood pressure in centenarians in Poland. J Hum Hypertens 18:713–716.  https://doi.org/10.1038/sj.jhh.1001728 CrossRefGoogle Scholar
  5. 5.
    Gareri P, Lacava R, Rossi M et al (1996) Hypertension in a group of centenarians. Arch Gerontol Geriatr 5:373–376CrossRefGoogle Scholar
  6. 6.
    Zhao W, Dong BR, Huang CQ et al (2010) Depression and hypertension among Chinese nonagenarians and centenarians. Int J Geriatr Psychiatry 25:554–561.  https://doi.org/10.1002/gps.2364 CrossRefGoogle Scholar
  7. 7.
    Moskalev AA, Aliper AM, Smit-McBride Z et al (2014) Genetics and epigenetics of aging and longevity. Cell Cycle 13:1063–1077.  https://doi.org/10.4161/cc.28433 CrossRefGoogle Scholar
  8. 8.
    Belmin J, Lévy BI, Michel J-B (1994) Changes in the renin-angiotensin-aldosterone axis in later life. Drugs Aging 5:391–400.  https://doi.org/10.2165/00002512-199405050-00007 CrossRefGoogle Scholar
  9. 9.
    Fallin MD, Matteini A (2009) Genetic epidemiology in aging research. J Gerontol A 64:47–60.  https://doi.org/10.1093/gerona/gln021 CrossRefGoogle Scholar
  10. 10.
    Winnicki M, Accurso V, Hoffmann M et al (2004) Physical activity and angiotensin-converting enzyme gene polymorphism in mild hypertensives. Am J Med Genet A 125A:38–44.  https://doi.org/10.1002/ajmg.a.20434 CrossRefGoogle Scholar
  11. 11.
    Sayed-Tabatabaei FA, Oostra BA, Isaacs A et al (2006) ACE polymorphisms. Circ Res 98:1123–1133.  https://doi.org/10.1161/01.RES.0000223145.74217.e7 CrossRefGoogle Scholar
  12. 12.
    Hu J, Miyatake F, Aizu Y et al (1999) Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population. Neurosci Lett 277:65–67.  https://doi.org/10.1016/S0304-3940(99)00827-7 CrossRefGoogle Scholar
  13. 13.
    Jeunemaitre X, Lifton RP, Hunt SC et al (1992) Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1:72–75.  https://doi.org/10.1038/ng0492-72 CrossRefGoogle Scholar
  14. 14.
    Cambien F, Alhenc-Gelas F, Herbeth B et al (1988) Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am J Hum Genet 43:774–780Google Scholar
  15. 15.
    Rigat B, Hubert C, Alhenc-Gelas F et al (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346.  https://doi.org/10.1172/JCI114844 CrossRefGoogle Scholar
  16. 16.
    Tiret L, Rigat B, Visvikis S et al (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197–205Google Scholar
  17. 17.
    Fagyas M, Úri K, Siket IM et al (2014) New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases. PLoS ONE 9:1–13.  https://doi.org/10.1371/journal.pone.0093719 Google Scholar
  18. 18.
    Keramatipour M, McConnell RS, Kirkpatrick P et al (2000) The ACE I allele is associated with increased risk for ruptured intracranial aneurysms. J Med Genet 37:498–500CrossRefGoogle Scholar
  19. 19.
    He L, Wang B, Lang W-Y et al (2015) Genetically-reduced serum ACE activity might be a causal risk factor for obstructive sleep apnea syndrome: a meta-analysis. Sci Rep 5:15267.  https://doi.org/10.1038/srep15267 CrossRefGoogle Scholar
  20. 20.
    San José G, Fortuño A, Moreno MU et al (2009) The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: potential implication in hypertension. Clin Sci (Lond) 116:233–240.  https://doi.org/10.1042/CS20080057 CrossRefGoogle Scholar
  21. 21.
    Arias-Vásquez A, Sayed-Tabatabaei FA, Schut AFC et al (2005) Angiotensin converting enzyme gene, smoking and mortality in a population-based study. Eur J Clin Invest 35:444–449.  https://doi.org/10.1111/j.1365-2362.2005.01515.x CrossRefGoogle Scholar
  22. 22.
    Bawazier L, Sja’bani M, Haryana S et al (2010) Relationship of angiotensin converting enzyme gene polymorphism and hypertension in Yogyakarta, Indonesia. Acta Med Indones 42:192–198Google Scholar
  23. 23.
    Sobti RC, Maithil N, Thakur H et al (2010) Association of ACE and FACTOR VII gene variability with the risk of coronary heart disease in north Indian population. Mol Cell Biochem 341:87–98.  https://doi.org/10.1007/s11010-010-0440-7 CrossRefGoogle Scholar
  24. 24.
    Schachter F, Faure-Delanef L, Guenot F et al (1994) Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 6:29–32CrossRefGoogle Scholar
  25. 25.
    Zajc Petranović M, Škarić-Jurić T, Smolej Narančić N et al (2012) Angiotensin-converting enzyme deletion allele is beneficial for the longevity of Europeans. Age (Dordr) 34:583–595.  https://doi.org/10.1007/s11357-011-9270-0 CrossRefGoogle Scholar
  26. 26.
    Rahmutula D, Nakayama T, Izumi Y et al (2002) Angiotensin-converting enzyme gene and longevity in the Xin Jiang Uighur autonomous region of China: an association study. J Gerontol Med Sci 57A:M57–M60.  https://doi.org/10.1093/gerona/57.1.M57 CrossRefGoogle Scholar
  27. 27.
    Garatachea N, Marín PJ, Lucia A (2013) The ACE DD genotype and D-allele are associated with exceptional longevity: a meta-analysis. Ageing Res Rev 12:1079–1087.  https://doi.org/10.1016/j.arr.2013.04.001 CrossRefGoogle Scholar
  28. 28.
    Galinsky D, Tysoe C, Brayne CE et al (1997) Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis 129:177–183.  https://doi.org/10.1016/S0021-9150(96)06027-3 CrossRefGoogle Scholar
  29. 29.
    Seripa D, Franceschi M, Matera MG et al (2006) Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy. J Gerontol A Biol Sci Med Sci 61:918–923CrossRefGoogle Scholar
  30. 30.
    Kolovou G, Kolovou V, Vasiliadis I et al (2014) The frequency of 4 common gene polymorphisms in nonagenarians, centenarians, and average life span individuals. Angiology 65:210–215.  https://doi.org/10.1177/0003319712475075 CrossRefGoogle Scholar
  31. 31.
    Montesanto A, Crocco P, Tallaro F et al (2013) Common polymorphisms in nitric oxide synthase (NOS) genes influence quality of aging and longevity in humans. Biogerontology 14:177–186.  https://doi.org/10.1007/s10522-013-9421-z CrossRefGoogle Scholar
  32. 32.
    Moncada S, Higgs EA (2006) The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 147:S193–S201.  https://doi.org/10.1038/sj.bjp.0706458 CrossRefGoogle Scholar
  33. 33.
    Liu S, Zeng F, Wang C et al (2015) The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer’s disease risk:a meta-analysis. Sci Rep 5:1–9.  https://doi.org/10.1038/srep13598 Google Scholar
  34. 34.
    Yan-yan L (2011) Endothelial nitric oxide synthase G894T gene polymorphism and essential hypertension in the Chinese population: a meta-analysis involving 11,248 subjects. Intern Med 50:2099–2106.  https://doi.org/10.2169/internalmedicine.50.5856 CrossRefGoogle Scholar
  35. 35.
    Veldman BA, Spiering W, Doevendans PA et al (2002) The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 20:2023–2027CrossRefGoogle Scholar
  36. 36.
    Rankinen T, Rice T, Pe L et al (2000) NOS3 Glu298Asp genotype and blood pressure response to endurance training. the HERITAGE family study. Hypertension 36:885–889CrossRefGoogle Scholar
  37. 37.
    Griendling KK, Sorescu D, Ushio-fukai M (2000) NAD(P)H oxidase role in cardiovascular biology and disease. Circ Res 86:494–501CrossRefGoogle Scholar
  38. 38.
    Mehta D, Malik AB (2006) Signaling mechanisms regulating endothelial permeability. Physiol Rev 86:279–367.  https://doi.org/10.1152/physrev.00012.2005 CrossRefGoogle Scholar
  39. 39.
    Lum H, Roebuck KA (2001) Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 280:C719–C741CrossRefGoogle Scholar
  40. 40.
    Pereira da Silva A, Matos A, Valente A et al (2015) Body composition assessment and nutritional status evaluation in men and women Portuguese centenarians. J Nutr Heal Aging 20:256–266.  https://doi.org/10.1007/s12603-015-0566-0 CrossRefGoogle Scholar
  41. 41.
    Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219.  https://doi.org/10.1093/eurheartj/eht151 CrossRefGoogle Scholar
  42. 42.
    James PA, Oparil S, Carter BL et al (2013) Evidence-based guideline for the management of high blood pressure in adults. JAMA 1097:1–14.  https://doi.org/10.1001/jama.2013.284427 Google Scholar
  43. 43.
    Pereira T, Maldonado J (2005) Validação de Aparelho de Medição Automática da Pressão Arterial COLSON MAM BP3AA1-2 Segundo o Protocolo da Sociedade Europeia de Hipertensão. Rev Port Cardiol 24:1341–1351Google Scholar
  44. 44.
    Sesso HD, Stampfer MJ, Rosner B et al (2000) Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension 36:801–807.  https://doi.org/10.1161/01.HYP.36.5.801 CrossRefGoogle Scholar
  45. 45.
    Weiss A, Boaz M, Beloosesky Y et al (2009) Pulse pressure predicts mortality in elderly patients. J Gen Intern Med 24:893–896.  https://doi.org/10.1007/s11606-009-1008-7 CrossRefGoogle Scholar
  46. 46.
    Martins L, Schettino L, Pereira R, Machado M (2008) Variações Hemodinâmicas em adultos jovens. Movimentym 3:1–10Google Scholar
  47. 47.
    Gobel FL, Norstrom L, Nelson RR et al (1978) The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation 57:549–556.  https://doi.org/10.1161/01.CIR.57.3.549 CrossRefGoogle Scholar
  48. 48.
    World Health Organization (2016) Global Report on DiabetesGoogle Scholar
  49. 49.
    WHO Technical Report Series (2000) Obesity: preventing and managing the global epidemic: report of a WHO consultation. Geneve, SwitzerlandGoogle Scholar
  50. 50.
    National Kidney Foundation (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratificationGoogle Scholar
  51. 51.
    Austad SN (2006) Why women live longer than men:sex differences in longevity. Gend Med 3:79–92.  https://doi.org/10.1016/S1550-8579(06)80198-1 CrossRefGoogle Scholar
  52. 52.
    INE (2012) Censos 2011: resultados definitivos. LisboaGoogle Scholar
  53. 53.
    Ferrari AU (2002) Modifications of the cardiovascular system with aging. Am J Geriatr Cardiol 11:30–33CrossRefGoogle Scholar
  54. 54.
    Mitchell GF, Gudnason V, Launer LJ et al (2008) Hemodynamics of increased pulse pressure in older women in the community-based age, gene/environment susceptibility-Reykjavik study. Hypertension 51:1123–1128.  https://doi.org/10.1161/HYPERTENSIONAHA.107.108175 CrossRefGoogle Scholar
  55. 55.
    Van Der Meer P, Lipsic E, Westenbrink BD et al (2005) Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation 112:1743–1747.  https://doi.org/10.1161/CIRCULATIONAHA.105.549121 CrossRefGoogle Scholar
  56. 56.
    Fleming I (2006) Signaling by the angiotensin-converting enzyme. Circ Res 98:887–896.  https://doi.org/10.1161/01.RES.0000217340.40936.53 CrossRefGoogle Scholar
  57. 57.
    Yang Y-H, Lai C-L, Tyan Y-C et al (2011) Angiotensin-converting enzyme gene and plasma protein level in Alzheimer’s disease in Taiwanese. Age Ageing 40:238–242.  https://doi.org/10.1093/ageing/afq179 CrossRefGoogle Scholar
  58. 58.
    Faure-Delanef L, Baudin B, Beaudoin J et al (1998) Plasma concentration, kinetic constants, and gene polymorphism of angiotensin I-converting enzyme in centenarians. Clin Chem 44:2083–2087Google Scholar
  59. 59.
    Hiraga H, Oshima T, Watanabe M et al (1996) Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. Hypertension 27:569–572CrossRefGoogle Scholar
  60. 60.
    Giner V, Poch E, Bragulat E et al (2000) Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension. Hypertension 35:512–517.  https://doi.org/10.1161/01.HYP.35.1.512 CrossRefGoogle Scholar
  61. 61.
    Poch E, González D, Giner V et al (2001) Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 38:1204–1209.  https://doi.org/10.1007/978-1-4419-7207-1 CrossRefGoogle Scholar
  62. 62.
    Ukraintseva S, Yashin A, Arbeev K et al (2015) Puzzling role of genetic risk factors in human longevity: “risk alleles” as pro-longevity variants. Biogerontology 17:109–127.  https://doi.org/10.1007/s10522-015-9600-1 CrossRefGoogle Scholar
  63. 63.
    Zhang L, Miyaki K, Araki J et al (2006) Interaction of angiotensin I-converting enzyme insertion-deletion polymorphism and daily salt intake influences hypertension in Japanese men. Hypertens Res 29:751–758.  https://doi.org/10.1291/hypres.29.751 CrossRefGoogle Scholar
  64. 64.
    Franco V, Oparil S (2006) Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival. J Am Coll Nutr 25:247S–255S.  https://doi.org/10.1080/07315724.2006.10719574 CrossRefGoogle Scholar
  65. 65.
    Oh SW, Han KH, Han SY et al (2015) Association of sodium excretion with metabolic syndrome, insulin resistance, and body fat. Medicine (United States) 94:e1650.  https://doi.org/10.1097/MD.0000000000001650 Google Scholar
  66. 66.
    Tzanetakou IP, Katsilambros NL, Benetos A et al (2012) “Is obesity linked to aging?”. Adipose tissue and the role of telomeres. Ageing Res Rev 11:220–229.  https://doi.org/10.1016/j.arr.2011.12.003 CrossRefGoogle Scholar
  67. 67.
    Schachter F, Faure-Delanef L, Guénot F et al (1994) Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 6:29–32.  https://doi.org/10.1038/ng0194-29 CrossRefGoogle Scholar
  68. 68.
    Marsden P, Heng HH, Scherer SW et al (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268:17478–17488Google Scholar
  69. 69.
    Shimasaki Y, Yasue H, Yoshimura M et al (1998) Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31:1506–1510.  https://doi.org/10.1016/S0735-1097(98)00167-3 CrossRefGoogle Scholar
  70. 70.
    Joshi MS, Mineo C, Shaul PW, Bauer JA (2007) Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J 21:2655–2663.  https://doi.org/10.1096/fj.06-7088com CrossRefGoogle Scholar
  71. 71.
    Nijiati M, Saidaming A, Qiao J et al (2013) GNB3, eNOS, and mitochondrial DNA polymorphisms correlate to natural longevity in a Xinjiang Uygur population. PLoS ONE 8:1–8.  https://doi.org/10.1371/journal.pone.0081806 CrossRefGoogle Scholar
  72. 72.
    Cam SF, Sekuri C, Tengiz I et al (2005) The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Thromb Res 116:287–292.  https://doi.org/10.1016/j.thromres.2004.12.002 CrossRefGoogle Scholar
  73. 73.
    Casas JP, Cavalleri GL, Bautista LE et al (2006) Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol 164:921–935.  https://doi.org/10.1093/aje/kwj302 CrossRefGoogle Scholar
  74. 74.
    Turner ST, Chapman AB, Schwartz GL, Boerwinkle E (2003) Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide. Am J Hypertens 16:834–839.  https://doi.org/10.1016/S0895-7061(03)01011-2 CrossRefGoogle Scholar
  75. 75.
    Tesauro M, Thompson WC, Rogliani P et al (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 97:2832–2835.  https://doi.org/10.1073/pnas.97.6.2832 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Genetics Laboratory and Environmental Health Institute-ISAMBFaculdade de Medicina da Universidade de LisboaLisbonPortugal
  2. 2.Instituto de Investigação Bento da Rocha CabralLisbonPortugal
  3. 3.Universitary Geriatric Unit of Faculdade de MedicinaUniversidade de LisboaLisbonPortugal
  4. 4.Centro Hospitalar Lisboa CentralLisbonPortugal
  5. 5.Molecular Oncology GroupPortuguese Institute of OncologyPortoPortugal
  6. 6.Academic Medical Centre of Lisboa - North of Lisboa Hospital CentreLisbonPortugal
  7. 7.Genetics Laboratory and Environmental Health Institute (ISAMB), Faculty of MedicineLisbon UniversityLisbonPortugal

Personalised recommendations